Evidence map›Paper›PMID 41051535›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

The clinical utility of total-body [

Qiaochu Chen, Wei Wang, Yining Wang, Liang Dong, Haitao Zhao, Lianghua Li, Gang Huang, Liu Liu, Ruohua Chen, Jianjun Liu

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Qiaochu Chen *Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Wei Wang *Department of Orthopaedic, School of Medicine, Renji Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, 200127, China.
Yining Wang *Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Liang DongDepartment of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Haitao ZhaoDepartment of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Lianghua LiDepartment of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Gang HuangDepartment of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Liu LiuDepartment of Nuclear Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. chestnuclear@126.com.
Ruohua ChenDepartment of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. crh19870405@163.com.
Jianjun LiuDepartment of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. nuclearj@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeBone metastasis significantly impacts morbidity and mortality in prostate cancer patients, necessitating accurate detection and monitoring. Although [

methodsThis retrospective study included 1211 prostate cancer patients who underwent total-body [

resultsApart from bone metastases, total-body [

conclusionsSAFOV PET/CT scanners with CFOV scan range may underestimate the true extent of bone metastasis. Total-body scan range using total-body PET/CT scanners revealed occult bone metastases in 5.12% of patients, particularly in those with higher PSA, Gleason scores, and CRPC stage. This extended view significantly impacts tumor burden quantification, leads to disease upstaging, and influences treatment planning. The developed nomogram can guide clinicians at centers with SAFOV PET/CT scanners in identifying patients who would most benefit from extended field-of-view imaging.

Indexed as

Bone NeoplasmsEdetic AcidOligopeptidesPositron Emission Tomography Computed TomographyProstatic NeoplasmsWhole Body ImagingAgedAged, 80 and overGallium IsotopesGallium RadioisotopesHumansMaleMiddle AgedRetrospective StudiesEdetic Acidgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesOligopeptidesPSMA-11Conventional field of viewNomogramsProstate cancerTotal-body [68 Ga]Ga-PSMA-11 PET/CT imagingTumor burden

Identifiers

PMID41051535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.